Breast ductal lavage for biomarker assessment in high risk women: rationale, design and methodology of a randomized phase II clinical trial with nimesulide, simvastatin and placebo

BACKGROUND: Despite positive results from large phase III clinical trials proved that it is possible to prevent estrogen-responsive breast cancers with selective estrogen receptor modulators and aromatase inhibitors, no significant results have been reached so far to prevent hormone non-responsive t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lazzeroni, Matteo, Guerrieri-Gonzaga, Aliana, Serrano, Davide, Cazzaniga, Massimiliano, Mora, Serena, Casadio, Chiara, Jemos, Costantino, Pizzamiglio, Maria, Cortesi, Laura, Radice, Davide, Bonanni, Bernardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522001/
https://www.ncbi.nlm.nih.gov/pubmed/23216985
http://dx.doi.org/10.1186/1471-2407-12-575

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522001/
https://www.ncbi.nlm.nih.gov/pubmed/23216985
http://dx.doi.org/10.1186/1471-2407-12-575

Ejemplares similares